[HTML][HTML] Elevated triglycerides and reduced high-density lipoprotein cholesterol are independently associated with the onset of advanced chronic kidney disease: A …
M Weldegiorgis, M Woodward - BMC nephrology, 2022 - Springer
Background Increased total cholesterol (TC), triglycerides (TG), low-density lipoprotein
cholesterol (LDL-C), and decreased high-density lipoprotein cholesterol (HDL-C) …
cholesterol (LDL-C), and decreased high-density lipoprotein cholesterol (HDL-C) …
Impact of the triglycerides to high-density lipoprotein cholesterol ratio on the incidence and progression of CKD: a longitudinal study in a large Japanese population
K Tsuruya, H Yoshida, M Nagata, T Kitazono… - American Journal of …, 2015 - Elsevier
Background The impact of the triglycerides to high-density lipoprotein cholesterol (TG: HDL-
C) ratio on chronic kidney disease (CKD) is unclear. Study Design Longitudinal cohort study …
C) ratio on chronic kidney disease (CKD) is unclear. Study Design Longitudinal cohort study …
Association between serum high‐density lipoprotein cholesterol levels and progression of chronic kidney disease: results from the KNOW‐CKD
Background High‐density lipoprotein cholesterol (HDL‐C) levels are generally decreased in
patients with chronic kidney disease (CKD). However, studies on the relationship between …
patients with chronic kidney disease (CKD). However, studies on the relationship between …
Association of the triglycerides to high-density lipoprotein cholesterol ratio with the risk of chronic kidney disease: analysis in a large Japanese population
K Tsuruya, H Yoshida, M Nagata, T Kitazono… - Atherosclerosis, 2014 - Elsevier
Objectives To investigate the relationship between triglycerides to high-density lipoprotein
cholesterol ratio (TG/HDL-C) and chronic kidney disease (CKD). Methods We used data …
cholesterol ratio (TG/HDL-C) and chronic kidney disease (CKD). Methods We used data …
Predictive value of triglyceride/high-density lipoprotein cholesterol for major clinical outcomes in advanced chronic kidney disease: a nationwide population-based …
Y Kim, S Lee, Y Lee, MW Kang, S Park… - Clinical Kidney …, 2021 - academic.oup.com
Background Dyslipidemia is an essential parameter in the prediction of cardiovascular
disease (CVD). We aimed to explore whether lipid profiles could predict major outcomes in …
disease (CVD). We aimed to explore whether lipid profiles could predict major outcomes in …
[HTML][HTML] Low levels of high-density lipoprotein cholesterol increase the risk of incident kidney disease and its progression
Available experimental evidence suggests a role for high-density lipoprotein cholesterol
(HDL-C) in incident chronic kidney disease (CKD) and its progression. However, clinical …
(HDL-C) in incident chronic kidney disease (CKD) and its progression. However, clinical …
[HTML][HTML] Association of dyslipidemia with renal outcomes in chronic kidney disease
Dyslipidemia is highly prevalent in patients with chronic kidney disease (CKD) and the
relationship between dyslipidemia with renal outcomes in patients with moderate to …
relationship between dyslipidemia with renal outcomes in patients with moderate to …
Total cholesterol to high-density lipoprotein cholesterol ratio is independently associated with CKD progression
W Li, Z Du, H Wei, J Dong - International Urology and Nephrology, 2022 - Springer
Purpose Although dyslipidemia can cause kidney damage, whether it independently
contributes to the progression of chronic kidney disease (CKD) remains controversial. The …
contributes to the progression of chronic kidney disease (CKD) remains controversial. The …
Low HDL cholesterol as a predictor of chronic kidney disease progression: a cross-classification approach and matched cohort analysis
K Kawachi, H Kataoka, S Manabe, T Mochizuki… - Heart and Vessels, 2019 - Springer
Emerging epidemiological evidence indicates that low serum high-density lipoprotein
cholesterol (HDL-C) levels are associated with the risk of progression of chronic kidney …
cholesterol (HDL-C) levels are associated with the risk of progression of chronic kidney …
[HTML][HTML] There is a U shaped association between non high density lipoprotein cholesterol with overall and cardiovascular mortality in chronic kidney disease stage 3 …
Dyslipidemia is common in patients with chronic kidney disease (CKD), however the
relationship between dyslipidemia and mortality in patients with moderate to severe CKD …
relationship between dyslipidemia and mortality in patients with moderate to severe CKD …